Profile
Carol Stuckley is currently an Independent Director at Transgene SA since 2023.
Former roles include Independent Director at Ipsen SA from 2017 to 2021, Independent Director at Epizyme, Inc. from 2021 to 2022, President & Director at Financial Executives International of Fort Worth Chapter, Independent Non-Executive Director at Centessa Pharmaceuticals Plc from 2021 to 2026, Vice President-Finance & Assistant Treasurer at Pfizer Inc., Chief Financial Officer & Senior VP-Finance at Galderma Laboratories LP from 2010 to 2013, and Chief Financial Officer & Senior Vice President at Healthcare Payment Specialists LLC from 2015 to 2019.
Education includes an undergraduate degree from the University of Delaware in 1977, and graduate degrees including an MBA from Fox School of Business in 1979 and 1980.
Carol Stuckley active positions
| Companies | Position | Start |
|---|---|---|
| TRANSGENE | Director/Board Member | 2023-05-04 |
Former positions of Carol Stuckley
| Companies | Position | End |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 2026-06-23 |
| EPIZYME, INC. | Director/Board Member | 2022-08-11 |
| IPSEN | Director/Board Member | 2021-07-31 |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Provides payment and reimbursement solutions | Director of Finance/CFO | 2019-06-30 |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Director of Finance/CFO | 2012-12-31 |
Training of Carol Stuckley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Develops and markets dermatology and prescription products | Health Technology |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Provides payment and reimbursement solutions | Commercial Services |
Fox School of Business
Fox School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Financial Executives International of Fort Worth Chapter | |
Centessa Pharmaceuticals Plc
Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
- Stock Market
- Insiders
- Carol Stuckley
















